Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Pharma's Almanac

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

Combining RNA Splicing and AI Technologies to Accelerate Drug Discovery and Development

Martin Akerman, Ph.D.

Envisagenics

Life Science Industrials

Life Science Industrials Are Key to the Growth of the Biopharma Industry

Reinhard Vogt

Dynamk Capital

Cell and Gene Therapy Technology

Advancing Technologies in Cell and Gene Therapy

Gustavo Mahler, Ph.D.

Dynamk Capital

Life Science Industrials

The Potential of Life Science Industrials

Daniella Kranjac

Dynamk Capital

Life Science Industrials

Filling Industry Gaps and Driving Innovation with Life Science Industrials

Reinhard Vogt; Sebastien Latapie

Dynamk Capital

The Future of Healthcare

How Does Dynamk Capital Envision the Future of the Pharma/Biopharma Industry?

Dynamk Capital

Organ-on-a-Chip

Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models

Gustavo Mahler, Ph.D.; Jessica Davis

Dynamk Capital

The Future of Healthcare

How Is Dynamk Capital Facing the Future of Healthcare?

Dynamk Capital

Partnership

Facilitating the Commercialization of Disruptive Industrial Life Science Technologies

Gustavo Mahler, Ph.D.; Daniella Kranjac

Dynamk Capital